'מערכת אימד'Abstract
Second-generation antipsychotics have demonstrated efficacy for patients with schizophrenia but are associated with wide-ranging side effects. Brexpiprazole, a serotonin-dopamine activity modulator, has demonstrated efficacy in adult patients with schizophrenia.
John M. Kane et al., Schizophrenia Research, Volume 174, Issues 1–3, 2016, Pages 93-98,
ISSN 0920-9964, https://doi.org/10.1016/j.schres.2016.04.013.